Literature DB >> 33622874

TBX15 rs98422, DNM3 rs1011731, RAD51B rs8017304, and rs2588809 Gene Polymorphisms and Associations With Pituitary Adenoma.

Gabija JuknytĖ1, Inga LaurinaitytĖ1, Alvita VilkeviČiŪtĖ2, Greta GedvilaitĖ3, Brigita GlebauskienĖ3, Loresa KriauČiŪnienĖ3, Rasa LiutkeviČienĖ3.   

Abstract

BACKGROUND: Pituitary adenoma (PA) is a benign tumor of parenchymal cells in the adenohypophysis, and it's development is strongly associated with genetic factors.This study aim was to find whether TBX15 rs98422, DNM3 rs1011731, RAD51B rs8017304, and rs2588809 single nucleotide polymorphisms can be associated with pituitary adenoma. While the TBX15 gene belongs to the T-box family of genes and is a transcription factor involved in many developmental processes, the DNM3 encodes a protein that is a member of the dynamin family with mechanochemical properties involved in actin-membrane processes, predominantly in membrane budding, and the RAD51B gene plays a significant role in homologous recombination in DNA repair for genome stability.
MATERIALS AND METHODS: The study enrolled 113 patients with pituitary adenoma and 283 healthy control subjects. DNA samples were extracted and purified from peripheral blood leukocytes. Genotyping was carried out using real-time polymerase chain reaction. The results were assessed using binomial logistic regression.
RESULTS: Our study revealed that RAD51B rs2588809 TT genotype could be associated with PA development in the co-dominant (OR=6.833; 95% CI=2.557-18.262; p<0.001) and recessive (OR=7.066; 95% CI=2.667-18.722; p<0.001) models. The same results were observed in females but not in males and PA without recurrence, while in PA with recurrence, no statistically significant results were obtained.
CONCLUSION: RAD51B rs2588809 TT genotype may increase the odds of PA development in women; it may also be associated with non-recurrent PA development. Copyright
© 2021, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  DNM3; Pituitary adenoma; RAD51B; TBX15; gene polymorphisms; prolactinoma

Mesh:

Substances:

Year:  2021        PMID: 33622874      PMCID: PMC8045120          DOI: 10.21873/invivo.12322

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  61 in total

1.  Novel antiapoptotic effect of TBX15: overexpression of TBX15 reduces apoptosis in cancer cells.

Authors:  Jéssica Arribas; Esteban Giménez; Ricard Marcos; Antonia Velázquez
Journal:  Apoptosis       Date:  2015-10       Impact factor: 4.677

2.  Anatomy of the cavernous sinus. A microsurgical study.

Authors:  F S Harris; A L Rhoton
Journal:  J Neurosurg       Date:  1976-08       Impact factor: 5.115

Review 3.  Pituitary adenomas: an overview.

Authors:  Marcy G Lake; Linda S Krook; Samya V Cruz
Journal:  Am Fam Physician       Date:  2013-09-01       Impact factor: 3.292

Review 4.  Biomarkers of aggressive pituitary adenomas.

Authors:  Ozgur Mete; Shereen Ezzat; Sylvia L Asa
Journal:  J Mol Endocrinol       Date:  2012-08-30       Impact factor: 5.098

5.  Associations of cholesteryl ester transfer protein (CETP) gene variants with pituitary adenoma.

Authors:  Agne Sidaraite; Rasa Liutkeviciene; Brigita Glebauskiene; Alvita Vilkeviciute; Loresa Kriauciuniene
Journal:  Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub       Date:  2019-04-17       Impact factor: 1.245

6.  Sellar and parasellar metastatic tumors.

Authors:  Tamer Altay; Khaled M Krisht; William T Couldwell
Journal:  Int J Surg Oncol       Date:  2011-10-13

7.  DNM3 Attenuates Hepatocellular Carcinoma Growth by Activating P53.

Authors:  Zhengdong Zhang; Chun Chen; Weike Guo; Shengbao Zheng; Zhenghua Sun; Xiaoping Geng
Journal:  Med Sci Monit       Date:  2016-01-19

8.  Overexpression of RAD51B predicts a preferable prognosis for non-small cell lung cancer patients.

Authors:  Mengyin Wu; Zufeng Sheng; Lingyan Jiang; Zhengyuan Liu; Yuhua Bi; Yueping Shen
Journal:  Oncotarget       Date:  2017-09-06

9.  Linc01278 inhibits the development of papillary thyroid carcinoma by regulating miR-376c-3p/DNM3 axis.

Authors:  Shaojian Lin; Langping Tan; Dingyuan Luo; Xinzhi Peng; Yue Zhu; Honghao Li
Journal:  Cancer Manag Res       Date:  2019-09-19       Impact factor: 3.989

10.  siPRDX2-elevated DNM3 inhibits the proliferation and metastasis of colon cancer cells via AKT signaling pathway.

Authors:  Yini Ma; Liying Guan; Yanxin Han; Yi Zhou; Xiaoming Li; Yumei Liu; Xiujuan Zhang; Weiying Zhang; Xiaohong Li; Shuhua Wang; Weidong Lu
Journal:  Cancer Manag Res       Date:  2019-06-28       Impact factor: 3.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.